Navigation Links
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Date:7/2/2009

NEW BRUNSWICK, N.J. and DUBLIN, July 2 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company. In addition, Johnson & Johnson, through its affiliate, will invest $1 billion in Elan in exchange for newly issued American Depositary Receipts (ADRs) of Elan which will represent 18.4% of Elan's outstanding ordinary shares.

The AIP Program represents Elan's interest in a collaboration with Wyeth to research, develop and commercialize selective products for the treatment and/or prevention of neurodegenerative conditions, including Alzheimer's disease.

Johnson & Johnson, through its affiliate, will assume and continue Elan's activities with Wyeth under the AIP Program and will initially commit up to $500 million to continue the development and launch activities of bapineuzumab, a potential first-in-class treatment that is being evaluated for slowing the progression of Alzheimer's disease, as well as other compounds. The agreement provides for additional funding obligations of the parties if needed.

In consideration for the transfer of these rights and assets, Elan will receive a 49.9% equity interest in the newly formed Johnson & Johnson company that will acquire the AIP Program. Elan will be entitled to a 49.9% share of the profits and certain royalty payments upon the commercialization of products under the collaboration with Wyeth.

The AIP Program includes multiple compounds being evaluated for slowing the progression of Alz
'/>"/>

SOURCE Johnson & Johnson; Elan Corporation plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
2. SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R)
3. American Dental Hygienists Association and Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. Announce Honorees of HYGIENIST HERO(R) Recognition Program
4. Senator Johnson Votes to Protect Americas Kids from Tobacco
5. PHOENIX-AHF/Magic Johnson HIV Testing Caravan & Southwest Center for HIV/AIDS to Host Free HIV Testing Event at Off Chute Too
6. Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
7. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
8. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
9. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
10. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
11. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau International ... Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from ... Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable ... on in Chicago at Grant Park. The festival will end on Sunday, August ... to Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... new industry players to know in predictive health analytics , Jvion continues ... technologies. The firm creates predictive software that targets patient and population level illness ...
(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy the summer ... to cook the next meal, making July the most appropriate to be National Hot ... and recipes. , Make the next cookout different than the ones in the past. ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... (Nasdaq: FLEX ) today announced that, in ... on October 1,2007, Solectron has notified holders of ... Nos. 834182 AR 8 and 834182 AS 6) ... 2034 (CUSIP No.,834182 AT) (together, the "Convertible Notes") ...
... BDSI, http://www.biodeliverysciences.com ) has submitted its New ... Drug Administration (FDA) for BEMATM Fentanyl, BDSIs treatment ... of the NDA represents a progression in a ... product, including the April 2007 announcement that BEMA ...
... Law Offices of Howard G. Smith,announces that a securities ... of the common stock of WellCare Health Plans, Inc.,("WellCare" ... 2006 and October,24, 2007, inclusive (the "Class Period"). The ... Court for the Middle District of,Florida. The Complaint ...
... Countries, Models at,Event Sponsored by AHIP and Kaiser Permanente, ... among countries in Europe that have universal health,coverage through ... role,in making care better and more affordable. There are ... all of their citizens, a fact,that argues for a ...
... can lower chances of malignancies , , WEDNESDAY, Oct. 31 ... are key to reducing your risk of cancer. And ... better off you,ll be, a new study suggests. , ... height and weight also influence cancer risk, according to ...
... only thing. former UCLA and Vanderbilt football coach Red ... a typical 10- to 15-year-old athlete, New research indicates that ... having fun and giving maximum effort is far more important ... won-loss record. , In terms of athletes ratings of how ...
Cached Medicine News:Health News:Flextronics Announces Change in Control Repurchase Offer for Solectron's 0.50% Senior Convertible Notes 2Health News:BDSI files FDA NDA for BEMA Fentanyl 2Health News:BDSI files FDA NDA for BEMA Fentanyl 3Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 3Health News:Obesity Linked to Increased Cancer Risk 2Health News:Obesity Linked to Increased Cancer Risk 3Health News:Motivational coaching climate outscores winning for young athletes 2
(Date:7/31/2015)... July 31, 2015 According to a ... (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services ... (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published by MarketsandMarkets, ... 6.1 Billion by 2020, at a CAGR of 7.6%.from 2015 ... market data T ables and 37 ...
(Date:7/31/2015)... and SAN DIEGO , July 31, ... company Eisai Co., Ltd. (Headquarters: Tokyo ... and Halozyme Therapeutics, Inc. (Headquarters: San Diego, ... Torley , "NASDAQ: HALO") have signed a clinical collaboration ... ® , "eribulin") in combination with Halozyme,s investigational drug ...
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... Reported sales decreased 4% as currency reduced sales growth ... per diluted share as reported (EPS) were $2.73, compared ... $2.80 , an increase of 9% over the ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... , Feb. 4 Accuray Incorporated (Nasdaq: ARAY ), ... for the second quarter of fiscal year 2010, ended December 31, ... reported total revenue of $57.3 million , compared to the second ... , Accuray reported a net loss for the second quarter of fiscal ...
... , , ATLANTA , Feb. ... for Economic and Clinical Health (HITECH) Act, Elekta has expanded its ... advantage of the financial incentives available from the federal government. These ... certified EMR systems who are able to demonstrate meaningful use. , ...
Cached Medicine Technology:Accuray Announces Results for Second Quarter Fiscal 2010 2Accuray Announces Results for Second Quarter Fiscal 2010 3Accuray Announces Results for Second Quarter Fiscal 2010 4Accuray Announces Results for Second Quarter Fiscal 2010 5Accuray Announces Results for Second Quarter Fiscal 2010 6Accuray Announces Results for Second Quarter Fiscal 2010 7Accuray Announces Results for Second Quarter Fiscal 2010 8Accuray Announces Results for Second Quarter Fiscal 2010 9Accuray Announces Results for Second Quarter Fiscal 2010 10Accuray Announces Results for Second Quarter Fiscal 2010 11Accuray Announces Results for Second Quarter Fiscal 2010 12Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 2Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines 3
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The product, which is comprised of a non-intrusive panty-liner, offers a simple to use classification tool that uses color identification for interpretation of the results....
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: